FluoroPharma Medical (PK) Stock Price

0.00 (0.0%)


52 Week Range


Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
FluoroPharma Medical Inc (PK) FPMI OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.0001 20:00:00
Open Price Low Price High Price Close Price Prev Close
Bid Price Ask Price Spread News
0.0001 0.0001 0.00 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0001 USD


Draw Mode:

FluoroPharma Medical Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.45k 34.49M 21.76M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
391.00 $ - - - -

more financials information »

FluoroPharma Medical (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FPMI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00110.00110.00010.000150,100-0.001-90.91%
1 Month0.00330.00330.00010.001138671,481-0.0032-96.97%
3 Months0.0120.0140.00010.0059828152,825-0.0119-99.17%
6 Months0.00760.0790.00010.0204559311,328-0.0075-98.68%
1 Year0.00220.0790.00010.0176879203,886-0.0021-95.45%
3 Years0.100.200.00010.0196051103,224-0.0999-99.9%
5 Years0.172550.250.00010.040090476,094-0.17245-99.94%

FluoroPharma Medical (PK) Description

We are a molecular imaging company headquartered in Montclair, NJ. The Company was founded to engage in the discovery, development and commercialization of proprietary products for the positron emission tomography (PET) market. The Company's initial focus has been on the development of novel cardiovascular imaging agents that can more efficiently and effectively detect and assess acute and chronic forms of coronary artery disease (CAD). Molecular imaging pharmaceuticals are radiopharmaceuticals that enable early detection of disease through the visualization of subtle changes in biochemical and biological processes.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.